Antibody Name/Symbol

Antibody Description

Clones/Alternate Names

α-1-antitrypsin

alpha 1 antitrypsin

Hepatoid Carcinoma

α-fetoprotein

alpha 1 fetoprotein

AFP, Z5A06, Clone C3

β-catenin

beta catenin; involved in regulation of cell adhesion and in signal transduction through Wnt pathway

B-catenin, CLONE 14, E-5, RB-9035Po, 17C2, 5H10

Borderline Clear Cell Adenofibroma; Clear Cell Carcinoma, Ovary; Germ Cell Tumors, Uterus; Hepatoid Carcinoma; Metastatic Melanoma; Microcystic Stromal Tumor; Sertoli-Leydig Cell Tumor; Yolk Sac Tumor, Vagina

34bE12

cytokeratin, high molecular weight (34bE12- CK 1, 5, 10, 14)

MA-903, CK903, 34βE12

Ectopic Prostate

Adipophilin

AP125

Extramammary Paget Disease; Sebaceous Carcinoma; Sebaceous Hyperplasia; Squamous Cell Carcinoma, Vulva; Vulvar Intraepithelial Neoplasia

AE1/3

mixture of 2 anticytokeratin clones that detect a variety of both high-and low- molecular weight cytokeratins

AE1/AE3

Adult Granulosa Cell Tumor; Benign Müllerian Lesions; Dysgerminoma; Fibroadenoma and Phyllodes Tumor; Gonadoblastoma; Malignant Mesothelioma, Peritoneum; Mesodermal Adenosarcoma; Müllerian Adenosarcoma, Cervix; Secondary Neoplasms, Uterus; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Steroid Cell Tumor, Not Otherwise Specified; Well-Differentiated Papillary Mesothelioma; Yolk Sac Tumor, Ovary

AE1/AE3

mixture of 2 anticytokeratin clones that detect a variety of both high-and low- molecular weight cytokeratins

AE1/3

Adenomatoid Tumor, Fallopian Tube; Basal Cell Carcinoma; Dysgerminoma; Florid Mesothelial Hyperplasia; Hidradenoma Papilliferum; Intraabdominal Desmoplastic Small Round Cell Tumor; Leydig Cell Tumor; Luteinized Thecoma With Sclerosing Peritonitis; Mesonephric Adenocarcinoma; Mixed Tumor, Vagina; Neuroendocrine Carcinomas, Corpus; Nongestational Choriocarcinoma; Peritoneal Inclusion Cysts; Primitive Neuroectodermal Tumor, Ovary; Sertoli Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Yolk Sac Tumor, Vagina

AFP

alpha 1 fetoprotein

α-fetoprotein, Z5A06, Clone C3

Dysgerminoma; Endometrioid Adenocarcinoma, Ovary; Hepatoid Carcinoma; Juvenile Granulosa Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Yolk Sac Tumor, Ovary

ALK1

anaplastic lymphoma kinase 1

5A4, ALKC

Leiomyosarcoma

AMACR

alpha-methylacyl CoA racemase

13H4, P504S

Ectopic Prostate; Müllerian Papilloma; Sebaceous Hyperplasia

Androgen receptor

Dihydrotestosterone receptor; nuclear receptor subfamily 3, group C, member 4

AR441, F39.4.1, AR-N20, AR27

Adenocarcinoma, Serous, Cervix; Ectopic Prostate; Mesonephric Remnants/Hyperplasia; Trichoepithelioma; Extramammary Paget Disease; Mesonephric Adenocarcinoma

Antichymotrypsin

alpha 1 antichromotrypsin

α-1-antichromotrypsin, A1ACT

Lymphomas and Leukemias of the Lower Genital Tract

Antitrypsin

alpha 1 antitrypsin

α-1-antitrypsin, A1AT

Lymphomas and Leukemias of the Lower Genital Tract

AR

androgen receptor

AR441, F39.4.1, AR-N20, AR27

Benign and Low-Grade Endometrial Stromal Tumors; Deep Glands and Cysts; Leiomyoma and Variants; Leiomyosarcoma; Müllerian Adenosarcoma, Cervix; Sebaceous Carcinoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors

ARID1a

AT-rich interactive domain-containing protein 1A

BAF250a

Mucinous Borderline Tumor, Endocervical Type

B72.3

tumor-associated glycoprotein-72

CC49, TAG-72, B72.3, BRST-3

Adenomatoid Tumor, Fallopian Tube; Bartholin Gland Carcinoma; Florid Mesothelial Hyperplasia; Malignant Mesothelioma, Peritoneum; Peritoneal Inclusion Cysts; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Well-Differentiated Papillary Mesothelioma

BAF250a

AT-rich interactive domain-containing protein 1A

ARID1a

Borderline Clear Cell Adenofibroma; Clear Cell Carcinoma, Ovary

Bcl-2

B-cell lymphoma 2; suppresses apoptosis in a variety of cell systems

ONCL2, BCL2/100/D5, 124, 124.3

Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Endometrioid; Basal Cell Carcinoma; Cervical Infections; Inflammatory Myofibroblastic Tumor; Leiomyosarcoma; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Mesonephric Remnants/Hyperplasia; Ovarian Lymphomas and Leukemias; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Trichoepithelioma; Tubal and Tuboendometrioid Metaplasia

Bcl-6

B-cell CLL/lymphoma 6

LN22, GI191E/A8, N-3, PG-B6P, P1F6, 3FR-1

Cervical Infections; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Lymphomas and Leukemias

BER-EP4

epithelial cell adhesion molecule

AUA1, VU-1D9, EPCAM, C10, HEA125

Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Basal Cell Carcinoma; Florid Mesothelial Hyperplasia; Intraabdominal Desmoplastic Small Round Cell Tumor; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Peritoneal Inclusion Cysts; Sebaceous Carcinoma; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Trichoepithelioma; Well-Differentiated Papillary Mesothelioma

BP180

transmembrane protein of the cutaneous basement membrane that plays an important role in epidermal-dermal adhesion

Herpes Gestationis

BRAF

serine/threonine-protein kinase Braf/proto-oncogene B-Raf/p94/v-Raf murine sarcoma viral oncogene homolog B1

Struma Ovarii

BRCA1

breast and ovarian cancer susceptibility protein 1

MS110

Endometrioid Adenocarcinoma, Fallopian Tube

C-erb-B2

v-erb-b2 erythroblastic leukemia viral gene protein, human epidermal growth factor receptor 2

HER2/neu, NEU, HER-2, NCLCBE1, 10A7, 9G6.10, SP3, 4B5, epidermal growth factor receptor 2, P185, 9G6.20, A0485, C-ERBB-2, CB11, ERBB-2, 3B5, TAB250, HERCEPTEST, E2-4001, HER-2_NEU

Clear Cell Adenocarcinoma, Corpus

C-Kit

tyrosine-protein kinase activity

CD117, C-19 (C-KIT), 104D2, 2E4, C-KIT, A4502, H300, CMA-767

Cervical Infections; Disseminated Peritoneal Leiomyomatosis; Extragastrointestinal Stromal Tumor; Fibromatous Neoplasms; Gonadoblastoma; Large Cell Neuroendocrine Carcinoma; Leiomyosarcoma; Lymphoma and Leukemia, Uterus; Malignant Melanoma, Vulva; Mesodermal Adenosarcoma; Müllerian Adenosarcoma, Cervix; Neuroendocrine Carcinomas, Corpus; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Ovarian Involvement by Gastrointestinal Stromal Tumor; Sertoli Cell Tumor; Smooth Muscle Tumors, Ovary; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor

CA125

OV185:1, CA 125, OC125

Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Intraabdominal Desmoplastic Small Round Cell Tumor; Metastatic Breast Carcinoma; Metastatic Colorectal Carcinoma; Serous Borderline Tumor, Ovary; Struma Ovarii

CA15-3

epithelial membrane antigen

EMA, GP1.4, 214D4, MC5, E29, MUC1, LICRLON- M8, BC3, DF3, VU3D1, MUSEII, RD-1, MA695, MA552, PS2P446, 115D8, MUC1, MAM6, CA15.3, MUC01

Sebaceous Carcinoma

CA19-9

tumor marker, cancer antigen 19-9, or sialylated Lewis A antigen

1116NS19-9

Malignant Mesothelioma, Peritoneum

CAE

gap junction protein

CAE1, CX50, CZP1, MP70, GJA8

Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Lymphomas and Leukemias

CAIX

carbonic anhydrase IX

CA9, ab1508, M75, NB100-417

Secondary Neoplasms, Vagina; Struma Ovarii

Calcitonin

polypeptide hormone produced by parafollicular cells (C cells) of the thyroid

CALBINDIN28

Carcinoid Tumor (Insular, Trabecular, and Mucinous); Neuroendocrine Tumors; Transitional Cell Metaplasia

Caldesmon

actin interacting and calmodulin binding protein found in smooth muscle and other cell types

Benign and Low-Grade Endometrial Stromal Tumors; Clear Cell Adenocarcinoma, Corpus; Granular Cell Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Leiomyosarcoma; Malignant Melanoma, Vagina; Malignant Mesothelioma, Peritoneum; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Squamous Cell Carcinoma, Vagina; Thecoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors

Calponin

thin filament-associated protein that is implicated in regulation and modulation of smooth muscle contraction

N3, 26A11, CALP, CNN1, SMCC, Sm Calp

Fibroadenoma and Phyllodes Tumor; Hidradenoma Papilliferum; Inflammatory Myofibroblastic Tumor; Mixed Tumor, Vulva

Calretinin

29 kDa calcium binding protein that is expressed in central and peripheral nervous system and in many normal and pathological tissues

DAK-CALRET, 5A5, CAL 3F5, DC8, AB149

Adenocarcinoma, Serous, Cervix; Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Benign and Low-Grade Endometrial Stromal Tumors; Benign Brenner Tumor; Dysgerminoma; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometriosis and Deciduosis; Female Adnexal Tumor of Probable Wolffian Origin; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; Follicular Cysts; Gonadoblastoma; Hepatoid Carcinoma; High-Grade Serous Adenocarcinoma; Juvenile Granulosa Cell Tumor; Leydig Cell Tumor; Luteinized Thecoma With Sclerosing Peritonitis; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Mesodermal Adenosarcoma; Mesonephric Adenocarcinoma; Mesonephric Remnants/Hyperplasia; Metastatic Melanoma; Microcystic Stromal Tumor; Müllerian Adenosarcoma, Cervix; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Sclerosing Stromal Tumor; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord Tumor With Annular Tubules; Sex Cord-Stromal Tumor, Not Otherwise Specified; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Solitary Fibrous Tumor, Peritoneum; Steroid Cell Tumor, Not Otherwise Specified; Stromal Hyperplasia and Hyperthecosis; Stromal Luteoma; Struma Ovarii; Strumal Carcinoid; Thecoma; Transitional Cell Carcinoma (Non-Brenner Type); Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Well-Differentiated Papillary Mesothelioma; Yolk Sac Tumor, Ovary

CAM 5.2

cytokeratin 8/18 (CAM5.2)

5D3, Zym5.2, 5D3, CAM 5.2, KER 10.11, NCL-5D3

Adenoid Basal Carcinoma; Adenomatoid Tumor, Fallopian Tube; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Bartholin Gland Carcinoma; Basal Cell Carcinoma; Extramammary Paget Disease; Intraabdominal Desmoplastic Small Round Cell Tumor; Malignant Melanoma, Vulva; Malignant Mesothelioma, Peritoneum; Mesonephric Adenocarcinoma; Müllerian Papilloma; Neuroendocrine Carcinomas, Corpus; Rhabdomyosarcoma, Corpus; Sebaceous Carcinoma; Sertoli Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified

Carbonic anhydrase IX

CAIX, CA9, ab1508, M75, NB100-417

Alveolar Soft Part Sarcoma

Carcinoembryonic antigen

carcinoembryonic antigen

CEA-M, mCEA, CEA-B18, CEA-D14, CEAGOLD 1, T84.6, CEA-GOLD 2, CEA 11, CEA-GOLD 3, CEA 27, CEAGOLD 4, CEA 41, CEA-GOLD 5, T84.1, CEA-M, A5B7, CEJ065, IL-7, T84.66, TF3H8-1, 0062, D14, alpha-7, PARLAM 1, ZC23, CEM010, A115, COL-1, AF4, 12.140.10, 11-7, M773, CEA-M431_31, CEJO65

Mucinous Adenocarcinoma, Corpus

CD1a

T-cell surface glycoprotein expressed in Langerhans cells as well as in leukemias

JPM30, CD1A, O10, NA1/34

Lymphomas and Leukemias of the Lower Genital Tract; Perivascular Epithelioid Cell (PEC) Proliferations

CD3

T-cell receptor

F7238, A0452, CD3-P, CD3-M, SP7, PS1

Inflammatory Myofibroblastic Tumor; Ovarian Lymphomas and Leukemias

CD4

T-cell surface glycoprotein L3T4

IF6, 1290, 4B12, 1F6, CD04

Chancroid; Fixed Drug Eruption; Inflammatory Myofibroblastic Tumor; Squamous Cell Carcinoma, Cervix

CD5

T-cell surface glycoprotein Leu1, T1

NCL-CD5, 4C7, 54/B4, 54/F6

Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Lymphomas and Leukemias; Undifferentiated Carcinoma, Corpus

CD8

T-cell coreceptor antigen, Leu 2, Tcytotoxic cells

M7103, C8/144, C8/144B

Fixed Drug Eruption; Inflammatory Myofibroblastic Tumor

CD9

motility-related protein-1 (MRP-1)

72F16, BA-2

Primitive Neuroectodermal Tumor, Peripheral and Central Types

CD10

neutral endopeptidase; germinal center marker positive that is also implicated in lymphoblastic leukemias

NCL-270, CALLA, neprilysin, NEP

Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Basal Cell Carcinoma; Benign and Low-Grade Endometrial Stromal Tumors; Benign Müllerian Lesions; Benign Serous Tumors, Ovary; Cervical Infections; Deciduosis; Deep Glands and Cysts; Ectopic Prostate; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid-Type Adenomyoma; Endometriosis and Deciduosis; Female Adnexal Tumor of Probable Wolffian Origin; Fibromatous Neoplasms; High-Grade Endometrial Stromal Sarcoma; Inflammatory Myofibroblastic Tumor; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Corpus; Mesodermal Adenosarcoma; Mesonephric Adenocarcinoma; Mesonephric Remnants/Hyperplasia; Metastatic Gastric Carcinoma; Microcystic Stromal Tumor; Mixed Tumor, Vagina; Müllerian Adenosarcoma, Cervix; Nongestational Choriocarcinoma; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Ovarian Involvement by Gastrointestinal Stromal Tumor; Ovarian Lymphomas and Leukemias; Perivascular Epithelioid Cell (PEC) Proliferations; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Pseudomyxoma Peritonei; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Sebaceous Carcinoma; Secondary Neoplasms, Vagina; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Solitary Fibrous Tumor, Peritoneum; Struma Ovarii; Thecoma; Trichoepithelioma; Tubal and Tuboendometrioid Metaplasia; Undifferentiated Carcinoma, Corpus; Undifferentiated Uterine Sarcoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Vaginal Cysts; Wilms Tumor

CD13

plays role in growth of DC/macrophage progenitors and precursors

Lymphomas and Leukemias of the Lower Genital Tract

CD14

coreceptor for lipopolysaccharide binding protein

FMC32

Lymphomas and Leukemias of the Lower Genital Tract

CD15

reacts with Reed-Sternberg cells of Hodgkin disease and with granulocytes

VIM-2, 3C4, LEU-M1, TU9, VIM-D5, MY1, CBD1, MMA, 3CD1, C3D1, Lewis x, SSEA-1

Florid Mesothelial Hyperplasia; Intraabdominal Desmoplastic Small Round Cell Tumor; Lymphomas and Leukemias of the Lower Genital Tract; Malignant Mesothelioma, Peritoneum; Sebaceous Carcinoma

CD19

B-cell antigen

Lymphoma and Leukemia, Uterus

CD20

B-lymphocyte antigen CD20/leukocyte surface antigen Leu-16

FB1, B1, L26, MS4A1

Cervical Infections; Inflammatory Myofibroblastic Tumor; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Lymphomas and Leukemias; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Undifferentiated Carcinoma, Corpus

CD23

Fc ε RII, low-affinity IgE receptor, IGEBF

1B12, MHM6BU38

Lymphoma and Leukemia, Uterus

CD25

If-2 receptor alpha

2A3, 4C9

Fixed Drug Eruption

CD30

tumor necrosis factor SF8

BER-H2, KI-1, TNFRSF8

Dysgerminoma; Inflammatory Myofibroblastic Tumor; Lymphomas and Leukemias of the Lower Genital Tract

CD31

platelet endothelial cell adhesion molecule

JC/70, JC/70A, PECAM-1

Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Peritoneal Inclusion Cysts; Squamous Cell Carcinoma, Vulva

CD34

hematopoietic progenitor cell antigen

MY10, IOM34, QBEND10, 8G12, 1309, HPCA-1, NU-4A1, TUK4, clone 581, BI-3c5

Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Angiomyofibroblastoma; Atypical Polypoid Adenomyoma; Basal Cell Carcinoma; Cellular Angiofibroma; Cervical Infections; Deep Aggressive Angiomyxoma; Dermatofibrosarcoma Protuberans; Disseminated Peritoneal Leiomyomatosis; Epithelioid Sarcoma; Extragastrointestinal Stromal Tumor; Fibroadenoma and Phyllodes Tumor; Fibromatous Neoplasms; Inflammatory Myofibroblastic Tumor; Leiomyosarcoma; Luteinized Thecoma With Sclerosing Peritonitis; Lymphomas and Leukemias of the Lower Genital Tract; Malignant Mesothelioma, Peritoneum; Malignant Mixed Müllerian Tumor, Corpus; Mesodermal Adenosarcoma; Mixed Tumor, Vagina; Müllerian Adenosarcoma, Cervix; Ovarian Involvement by Gastrointestinal Stromal Tumor; Perivascular Epithelioid Cell (PEC) Proliferations; Prepubertal Vulval Fibroma; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Solitary Fibrous Tumor, Vulva; Squamous Cell Carcinoma, Vulva; Superficial Angiomyxoma; Trichoepithelioma

CD43

major sialoglycoprotein on surface of human T lymphocytes, monocytes, granulocytes, and some B lymphocytes

LEU-22, DF-T1, L60, MT1, sialophorin, leukosialin, SPN

Cervical Infections; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Neuroendocrine Tumors; Ovarian Lymphomas and Leukemias

CD45

leukocyte common antigen

LCA, PD7/26, 1.22/4.14, T29/33, RP2/18, PD7, 2D1, 2B11+PD7/26

Adult Granulosa Cell Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Lymphomas and Leukemias; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Undifferentiated Carcinoma, Corpus

CD56

neutral cellular adhesion molecule

MAB735, ERIC-1, 25-KD11, 123C3, 24-MB2, BC56C04, 1B6, 14-MAB735, NCC-LU-243, MOC-1, NCAM

Adenoid Basal Carcinoma; Adenoid Cystic Carcinoma; Adult Granulosa Cell Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Endometrioid Adenocarcinoma, Ovary; Endometriosis and Deciduosis; Fibromatous Neoplasms; Gonadoblastoma; Immature Teratoma; Juvenile Granulosa Cell Tumor; Large Cell Neuroendocrine Carcinoma; Luteinized Thecoma With Sclerosing Peritonitis; Malignant Mesothelioma, Peritoneum; Malignant Mixed Mesodermal Tumor; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Corpus; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Struma Ovarii; Thecoma; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Undifferentiated Carcinoma, Corpus; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Wilms Tumor

CD57

β-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)

LEU-7, NK1, HNK-1, TB01, B3GAT1

Intraabdominal Desmoplastic Small Round Cell Tumor

CD68

cytoplasmic granule protein of monocytes, macrophages

PG-M1, KP-1

Cervical Infections; Deciduosis; Epithelioid Sarcoma; Granular Cell Tumor; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Mucinous Cystic Tumor with Mural Nodules; Ovarian Lymphomas and Leukemias; Verruciform Xanthoma

CD79a

immunoglobulin-associated alpha, MB1

MB-1, 11D10, 11E3, CD79A, HM47/A9, HM57, JCB117, CD79a, CD79-α

Lymphomas and Leukemias of the Lower Genital Tract; Lymphoma and Leukemia, Uterus

CD99

cell surface glycoprotein for migration, T cell adhesion, MIC2

CD99-MEMB, MIC2, 12E7, HBA71, O13, P30/32MIC2, M3601

Adult Granulosa Cell Tumor; Benign and Low-Grade Endometrial Stromal Tumors; Endometrioid Adenocarcinoma, Ovary; Intraabdominal Desmoplastic Small Round Cell Tumor; Juvenile Granulosa Cell Tumor; Leydig Cell Tumor; Malignant Mixed Mesodermal Tumor; Mixed Tumor, Vagina; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Solitary Fibrous Tumor, Peritoneum; Solitary Fibrous Tumor, Vulva; Steroid Cell Tumor, Not Otherwise Specified; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Wilms Tumor

CD117

C-kit, tyrosine-protein kinase activity

C-19 (C-KIT), 104D2, 2E4, C-KIT, A4502, H300, CMA-767

Dysgerminoma; Extragastrointestinal Stromal Tumor; High-Grade Endometrial Stromal Sarcoma; Inflammatory Myofibroblastic Tumor; Leiomyosarcoma; Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Involvement by Gastrointestinal Stromal Tumor; Perivascular Epithelioid Cell (PEC) Proliferations; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Secondary Neoplasms, Vagina; Solitary Fibrous Tumor, Peritoneum; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Yolk Sac Tumor, Ovary

CD138

syndecan; a useful marker for plasma cells

B-B4, AM411-10M, MI15

Endometritis

CD146

melanoma cell adhesion molecule

MCAM

Deciduosis

CDX-2

caudal-type homeobox transcription factor 2

AMT28, 7C7/D4, CDX-2-88

Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell; Carcinoma; Benign Brenner Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Endocervicosis; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Extramammary Paget Disease; Metastatic Appendiceal Tumors; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Pancreaticobiliary Adenocarcinoma; Metastatic/Secondary Tumors to the Cervix; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Intestinal Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Pseudomyxoma Peritonei; Secondary Neoplasms, Uterus; Secondary Neoplasms, Vagina; Strumal Carcinoid

CEA

carcinoembryonic antigen

mCEA, CEA-B18, CEA-D14, CEAGOLD 1, T84.6, CEA-GOLD 2, CEA 11, CEA-GOLD 3, CEA 27, CEAGOLD 4, CEA 41, CEA-GOLD 5, T84.1, CEA-M, A5B7, CEJ065, IL-7, T84.66, TF3H8-1, 0062, D14, alpha-7, PARLAM 1, ZC23, CEM010, A115, COL-1, AF4, 12.140.10, 11-7, M773, CEA-M431_31, CEJO65

Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Adenocarcinoma, Villoglandular; Adenoid Basal Carcinoma; Adenoid Cystic Carcinoma; Adenomatoid Tumor, Corpus; Adenosquamous Carcinoma Including Glassy Cell Carcinoma; Bartholin Gland Carcinoma; Eccrine Spiradenoma; Endocervical-Type Adenomyoma; Endometrial Metaplasias; Extramammary Paget Disease; Florid Mesothelial Hyperplasia; Malignant Mesothelioma, Ovary; Mesonephric Adenocarcinoma; Microcystic Adnexal Carcinoma; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Corpus; Müllerian Papilloma; Neuroendocrine Tumors; Peritoneal Inclusion Cysts; Syringoma

Chromogranin

pituitary secretory protein 1

Chromogranin A, PHE-5, PHE5, E001, DAK-A3

Adult Granulosa Cell Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Juvenile Granulosa Cell Tumor; Malignant Mixed Mesodermal Tumor; Metastatic Appendiceal Tumors; Metastatic Lung Carcinoma; Neuroendocrine Carcinomas, Corpus; Primitive Neuroectodermal Tumor, Ovary; Rhabdomyosarcoma, Corpus; Small Cell Carcinoma, Pulmonary Type; Struma Ovarii; Strumal Carcinoid

Chromogranin A

pituitary secretory protein 1

PHE-5, PHE5, E001, DAK-A3

Adenocarcinoma, Minimal Deviation

CK1

cytokeratin 1

CK 01, 34BB4

Mesonephric Adenocarcinoma

CK5

cytokeratin 5

XM26, RCK103, 34BEH12

Adenomatoid Tumor, Fallopian Tube; Malignant Mesothelioma, Peritoneum; Metastatic Lung Carcinoma; Microcystic Adnexal Carcinoma; Peritoneal Inclusion Cysts; Syringoma; Trichoepithelioma

CK5/6

cytokeratin 5/6, high molecular weight cytokeratins

D5/16 B4

Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Benign Müllerian Lesions; Florid Mesothelial Hyperplasia; Hidradenoma Papilliferum; Malignant Mesothelioma, Peritoneum; Metastatic Lung Carcinoma; Peritoneal Inclusion Cysts; Sebaceous Carcinoma; Squamous Cell Carcinoma, Vagina

CK7

cytokeratin 7, low molecular weight cytokeratin

K72.7, KS7.18, OVTL 12/30, LDS-68, CK 07

Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell; Carcinoma; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Benign Brenner Tumor; Benign Müllerian Lesions; Borderline Clear Cell Adenofibroma; Clear Cell Carcinoma, Ovary; Clear Cell Carcinoma, Vagina; Eccrine Spiradenoma; Endocervicosis; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid Borderline Tumor; Endometriosis and Deciduosis; Extramammary Paget Disease; Female Adnexal Tumor of Probable Wolffian Origin; Fibroadenoma and Phyllodes Tumor; Hepatoid Carcinoma; Hidradenoma Papilliferum; Large Cell Neuroendocrine Carcinoma; Malignant Brenner Tumor; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Mesonephric Adenocarcinoma; Metastatic Appendiceal Tumors; Metastatic Cervical Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Lung Carcinoma; Metastatic Pancreaticobiliary Adenocarcinoma; Microcystic Adnexal Carcinoma; Mixed Tumor, Vagina; Mixed Tumor, Vulva; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Endocervical Type; Mucinous Borderline Tumor, Intestinal Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Neuroendocrine Carcinomas, Corpus; Proliferating/Borderline Brenner Tumor; Pseudomyxoma Peritonei; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Signet Ring Cell Stromal Tumor; Squamous Cell Carcinoma, Cervix; Strumal Carcinoid; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Vaginal Intraepithelial Neoplasia; Yolk Sac Tumor, Ovary; Yolk Sac Tumor, Vagina

CK13

cytokeratin 13

KS13.1, KS-1A3, AE8, 2D7

Transitional Cell Metaplasia

CK14

cytokeratin 14, high molecular weight cytokeratin

LL002

Microcystic Adnexal Carcinoma

CK15

cytokeratin 15

LHK15

Basal Cell Carcinoma; Trichoepithelioma; Trichofolliculoma

CK17

cytokeratin 17

E3

Microcystic Adnexal Carcinoma; Mucinous Borderline Tumor, Endocervical Type; Transitional Cell Metaplasia

CK18

cytokeratin 18

M9, DC-10, CY-90, KS18.04

Adenomatoid Tumor, Fallopian Tube; Hepatoid Carcinoma; Leiomyosarcoma; Squamous Cell Carcinoma, Cervix; Transitional Cell Metaplasia; Trichoepithelioma; Undifferentiated Carcinoma, Corpus; Undifferentiated Uterine Sarcoma

CK19

cytokeratin 19, low molecular weight cytokeratin

BA17, RCK108, LP2K, B170, A53-BA2, KS19.1, 170.2.14

Hepatoid Carcinoma; Sebaceous Carcinoma

CK20

cytokeratin 20, low molecular weight cytokeratin

KS20.8

Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell; Carcinoma; Basal Cell Carcinoma; Benign Brenner Tumor; Dysgerminoma; Endocervicosis; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Extramammary Paget Disease; Female Adnexal Tumor of Probable Wolffian Origin; Hepatoid Carcinoma; Large Cell Neuroendocrine Carcinoma; Malignant Brenner Tumor; Malignant Melanoma, Vulva; Mesonephric Adenocarcinoma; Metastatic Appendiceal Tumors; Metastatic Cervical Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Pancreaticobiliary Adenocarcinoma; Metastatic/Secondary Tumors to the Cervix; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Intestinal Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Müllerian Papilloma; Proliferating/Borderline Brenner Tumor; Pseudomyxoma Peritonei; Secondary Neoplasms, Uterus; Secondary Neoplasms, Vagina; Serous Carcinoma, Peritoneum; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Squamous Cell Carcinoma, Vagina; Strumal Carcinoid; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Transitional Cell Metaplasia; Yolk Sac Tumor, Vagina

CK903

cytokeratin-HMW, not otherwise specified

CK-HMW-NOS, CK-HMW, HMWCK, 34bE12

Basal Cell Carcinoma; Sebaceous Carcinoma; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva

CK-PAN

cytokeratin-pan (AE1/AE3/LP34); cocktail of high and low molecular weight cytokeratins

keratin pan, MAK-6, K576, LU-5, KL-1, KC-8, MNF 116, pankeratin, pancytokeratin

Benign and Low-Grade Endometrial Stromal Tumors; Squamous Cell Carcinoma, Vulva

Claudin-4

3E2C1

High-Grade Serous Adenocarcinoma; Malignant Mesothelioma, Peritoneum; Serous Carcinoma, Peritoneum

CMV

cytomegalovirus

Cervical Infections; Endometritis

Collagen IV

major constituent of the basement membranes along with laminins, proteoglycans, and enactins

CIV22, COL4A [1-5], collagen α-1(IV) chain

Bartholin Gland Carcinoma

Cyclin-D1

protein with important cell cycle regulatory functions

bcl-1 (cyclin D1) A-12, PRAD1, AM29, DCS-6, SP4, 5D4, D1GM, P2D11F11, CCND1Cyl-1

Clear Cell Adenocarcinoma, Corpus; Extragastrointestinal Stromal Tumor; High-Grade Endometrial Stromal Sarcoma; Leiomyosarcoma; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Transitional Cell Carcinoma (Non-Brenner Type); Undifferentiated Uterine Sarcoma

Cytokeratin

Adenocarcinoma, Intestinal Including Gastric and Signet Ring Cell; Alveolar Soft Part Sarcoma; Deciduosis; Endometrioid Adenocarcinoma and Variants, Corpus; Epithelioid Sarcoma; Female Adnexal Tumor of Probable Wolffian Origin; Large Cell Neuroendocrine Carcinoma; Leiomyosarcoma; Malignant Mixed Müllerian Tumor, Cervix; Metaplastic Papillary Tumor; Metastatic Pancreaticobiliary Adenocarcinoma; Microcystic Adnexal Carcinoma; Microcystic Stromal Tumor; Mixed Tumor, Vulva; Mucinous Adenocarcinoma, Ovary; Mucinous Cystic Tumor with Mural Nodules; Neuroendocrine Tumors; Perivascular Epithelioid Cell (PEC) Proliferations; Rhabdomyosarcoma, Cervix; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Solitary Fibrous Tumor, Peritoneum; Squamous Cell Carcinoma, Vulva; Well-Differentiated Papillary Mesothelioma; Stromal Luteoma

Cytokeratin 5

Epithelioid Sarcoma; Intraabdominal Desmoplastic Small Round Cell Tumor

Cytokeratin 5/6

cytokeratin 5/6, high molecular weight cytokeratins

D5/16 B4

Squamous Cell Carcinoma, Vulva; Epithelioid Sarcoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Serous Borderline Tumor, Peritoneum; Squamous Cell Carcinoma, Vulva; Well-Differentiated Papillary Mesothelioma

Cytokeratin 6

CK6, LL020, LHK6B, CK 06

Epithelioid Sarcoma

Cytokeratin 7

cytokeratin 7, low molecular weight cytokeratin

K72.7, KS7.18, OVTL 12/30, LDS-68, CK 07

Adenoid Basal Carcinoma; Alveolar Soft Part Sarcoma; Metastatic Pancreaticobiliary Adenocarcinoma; Well-Differentiated Papillary Mesothelioma

Cytokeratin 18

cytokeratin 18

M9, DC-10, CY-90, KS18.04

Malignant Mixed Müllerian Tumor, Corpus

Cytokeratin 20

cytokeratin 20, low molecular weight cytokeratin

KS20.8

Intraabdominal Desmoplastic Small Round Cell Tumor; Metastatic Pancreaticobiliary Adenocarcinoma; Mucinous Adenocarcinoma, Ovary

D2-40

reacts with an O-linked sialoglycoprotein found on lymphatic endothelium

podoplanin, M2A, D2-40

Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Basal Cell Carcinoma; Benign Müllerian Lesions; Dysgerminoma; Eccrine Spiradenoma; Endometriosis and Deciduosis; Extramammary Paget Disease; Florid Mesothelial Hyperplasia; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Microcystic Adnexal Carcinoma; Peritoneal Inclusion Cysts; Sebaceous Carcinoma; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Trichoepithelioma; Well-Differentiated Papillary Mesothelioma; Yolk Sac Tumor, Ovary

Desmin

class III intermediate filaments found in muscle cells

M760, DE-R-11, D33, DE5, DE-U-10, ZC18

Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Angiomyofibroblastoma; Atypical Polypoid Adenomyoma; Benign and Low-Grade Endometrial Stromal Tumors; Benign Müllerian Lesions; Cellular Angiofibroma; Clear Cell Adenocarcinoma, Corpus; Deep Aggressive Angiomyxoma; Dermatofibrosarcoma Protuberans; Disseminated Peritoneal Leiomyomatosis; Endocervical-Type Adenomyoma; Extragastrointestinal Stromal Tumor; Fibroepithelial Stromal Polyp; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; Granular Cell Tumor; High-Grade Endometrial Stromal Sarcoma; Inflammatory Myofibroblastic Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Intravenous Leiomyomatosis; Juvenile Granulosa Cell Tumor; Leiomyoma and Variants; Leiomyosarcoma; Luteinized Thecoma With Sclerosing Peritonitis; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Cervix; Malignant Mixed Müllerian Tumor, Corpus; Massive Vulval Edema; Mesodermal Adenosarcoma; Mixed Tumor, Vagina; Müllerian Adenosarcoma, Cervix; Müllerian Papilloma; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Ovarian Involvement by Gastrointestinal Stromal Tumor; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Polyps; Prepubertal Vulval Fibroma; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Solitary Fibrous Tumor, Vulva; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Superficial Angiomyxoma; Thecoma; Undifferentiated Uterine Sarcoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Wilms Tumor; Yolk Sac Tumor, Vagina

DOG1

transmembrane protein 16A

DOG1 (TMEM16A), DOG 1.1

Disseminated Peritoneal Leiomyomatosis; Extragastrointestinal Stromal Tumor; Fibromatous Neoplasms; High-Grade Endometrial Stromal Sarcoma; Inflammatory Myofibroblastic Tumor; Leiomyosarcoma; Mesodermal Adenosarcoma; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Ovarian Involvement by Gastrointestinal Stromal Tumor; Secondary Neoplasms, Vagina; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum

E-cadherin

epithelial calcium dependent adhesion molecule

36B5, ECH-6, ECCD-2, CDH1, 5H9, NCH 38, Clone 36, 4A2 C7, E9, 67A4, HECD-1, SC-8426

Clear Cell Adenocarcinoma, Corpus; High-Grade Serous Adenocarcinoma; Malignant Mixed Müllerian Tumor, Corpus

EBER

Epstein-Barr virus encoded RNA

Cervical Infections

EGFR

v-erb b1 erythroblastic leukemia viral gene, epidermal growth factor receptor

2-18C9, EGFR1, EGFR PHRMDX, NCLR1, H11, C-ERBB-1, E30, EGFR. 113, 31G73C6, 2-18C9

Transitional Cell Carcinoma (Non-Brenner Type)

EMA

epithelial membrane antigen

GP1.4, 214D4, MC5, E29, MUC1, EMA/MUC1

Adenocarcinoma, Endometrioid, Cervix; Adenoid Cystic Carcinoma; Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Bartholin Gland Carcinoma; Benign Brenner Tumor; Benign Müllerian Lesions; Clear Cell Adenocarcinoma, Corpus; Clear Cell Carcinoma, Ovary; Clear Cell Carcinoma, Vagina; Deciduosis; Dysgerminoma; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Epithelioid Sarcoma; Extramammary Paget Disease; Female Adnexal Tumor of Probable Wolffian Origin; Florid Mesothelial Hyperplasia; Germ Cell Tumors, Uterus; Inflammatory Myofibroblastic Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Intravenous Leiomyomatosis; Juvenile Granulosa Cell Tumor; Large Cell Neuroendocrine Carcinoma; Large Solitary Luteinized Follicle Cyst of Pregnancy; Leiomyoma and Variants; Leiomyosarcoma; Luteinized Thecoma With Sclerosing Peritonitis; Malignant Melanoma, Vulva; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Cervix; Malignant Mixed Müllerian Tumor, Corpus; Mesonephric Adenocarcinoma; Mesonephric Remnants/Hyperplasia; Metaplastic Papillary Tumor; Metastatic Appendiceal Tumors; Metastatic Melanoma; Microcystic Adnexal Carcinoma; Microcystic Stromal Tumor; Mixed Tumor, Vagina; Mixed Tumor, Vulva; Müllerian Papilloma; Neuroendocrine Tumors; Nongestational Choriocarcinoma; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Proliferating/Borderline Brenner Tumor; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Sebaceous Carcinoma; Sebaceous Hyperplasia; Serous Carcinoma (Including STIC); Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord Tumor With Annular Tubules; Sex Cord-Stromal Tumor, Not Otherwise Specified; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Solitary Fibrous Tumor, Vulva; Syringoma; Thecoma; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Undifferentiated Carcinoma, Corpus; Undifferentiated Uterine Sarcoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Yolk Sac Tumor, Ovary; Yolk Sac Tumor, Vagina

Epithelial membrane antigen

EMA, GP1.4, 214D4, MC5, E29, MUC1, EMA/MUC1

Endometrioid Adenocarcinoma and Variants, Corpus; Intraabdominal Desmoplastic Small Round Cell Tumor; Smooth Muscle Tumors, Vulva

ER

estrogen receptor protein

ERP, 1D5, 6F11, SP1, 15D, H222, TE111, ERP, ER1D5, NCLER611, NCL-ER-LH2, PGP-1A6

Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Angiomyofibroblastoma; Atypical Polypoid Adenomyoma; Benign and Low-Grade Endometrial Stromal Tumors; Benign Müllerian Lesions; Benign Serous Tumors, Ovary; Borderline Clear Cell Adenofibroma; Clear Cell Adenocarcinoma, Corpus; Clear Cell Carcinoma, Ovary; Deep Aggressive Angiomyxoma; Disseminated Peritoneal Leiomyomatosis; Endocervicosis; Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid Borderline Tumor; Endometriosis and Deciduosis; Endometriosis, Cervix; Extragastrointestinal Stromal Tumor; Extramammary Paget Disease; Fibroadenoma and Phyllodes Tumor; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; Hepatoid Carcinoma; Hidradenoma Papilliferum; High-Grade Endometrial Stromal Sarcoma; High-Grade Serous Adenocarcinoma; Inflammatory Myofibroblastic Tumor; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Low-Grade Serous Adenocarcinoma; Luteinized Thecoma With Sclerosing Peritonitis; Lymphoma and Leukemia, Uterus; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Malignant Mixed Müllerian Tumor, Corpus; Mesodermal Adenosarcoma; Mesonephric Adenocarcinoma; Metastatic Breast Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Uterine Corpus Carcinoma to Ovary; Metastatic/Secondary Tumors to the Cervix; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Corpus; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Endocervical Type; Mucinous Borderline Tumor, Intestinal Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Müllerian Adenosarcoma, Cervix; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Polyps; Proliferating/Borderline Brenner Tumor; Rhabdomyoma; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Secondary Neoplasms, Uterus; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Sex Cord-Stromal Tumor, Not Otherwise Specified; Small Cell Carcinoma, Pulmonary Type; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Squamous Cell Carcinoma, Corpus; Stromal Luteoma; Syringoma; Thecoma; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Tubal and Tuboendometrioid Metaplasia; Undifferentiated Carcinoma, Corpus; Undifferentiated Uterine Sarcoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Wilms Tumor; Yolk Sac Tumor, Vagina

ERG

Squamous Cell Carcinoma, Vulva

Estrogen receptor

ER, ERP, 1D5, 6F11, SP1, 15D, H222, TE111, ERP, ER1D5, NCLER611, NCLER-LH2, PGP-1A6

Fibroepithelial Stromal Polyp; Polyps; Prepubertal Vulval Fibroma

Factor VIII

factor VIII-related antigen

FVIIIRAg, F8/86, von Willenbrand factor

Adenomatoid Tumor, Corpus

Fascin

marker for Reed-Sternberg cells of Hodgkin disease

55K2

Metastatic Pancreaticobiliary Adenocarcinoma

Fibrin

mouse IgG Ab against β chain of fibrin that recognizes both murine and human fibrin

Endometrioid Adenocarcinoma and Variants, Corpus; Florid Mesothelial Hyperplasia; Perivascular Epithelioid Cell (PEC) Proliferations; Squamous Cell Carcinoma, Cervix

FLI-1

Friend leukemia virus integration 1

EWSR2, GI146-222, SC356, FLK-1, FLT-1

Benign and Low-Grade Endometrial Stromal Tumors; Intraabdominal Desmoplastic Small Round Cell Tumor; Malignant Mixed Mesodermal Tumor; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Wilms Tumor

FOXL2

Adult Granulosa Cell Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Fibromatous Neoplasms; Leydig Cell Tumor; Luteinized Thecoma With Sclerosing Peritonitis; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Proliferating/Borderline Brenner Tumor; Serous Borderline Tumor, Ovary; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Thecoma; Transitional Cell Carcinoma (Non-Brenner Type)

FSH

follicle stimulating hormone

Autoimmune Oophoritis

Galectin-3

NCL-GAL3, B2C10, 9C4

Struma Ovarii

GATA3

endothelial transcription factor 3

Adenocarcinoma, Usual Type; Deep Glands and Cysts; Endometrioid Adenocarcinoma, Ovary; Female Adnexal Tumor of Probable Wolffian Origin; Lymphoma and Leukemia, Uterus; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Proliferating/Borderline Brenner Tumor; Sclerosing Stromal Tumor; Secondary Neoplasms, Vagina; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Squamous Cell Carcinoma, Vagina; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube

GCDFP-15

gross cystic disease fluid protein 15

SABP, GPIP4, Gp17, 23A3, BRST-2, D6

Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Extramammary Paget Disease; Hidradenoma Papilliferum; Leiomyosarcoma; Lymphoma and Leukemia, Uterus; Malignant Melanoma, Vulva; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Microcystic Adnexal Carcinoma; Sclerosing Stromal Tumor; Secondary Neoplasms, Vagina; Serous Carcinoma (Including STIC); Vaginal Intraepithelial Neoplasia; Vulvar Intraepithelial Neoplasia

GFAP

intermediate filament expressed by numerous cells of the CNS

6F2, M761, GA-51, GFP-8A

Benign and Low-Grade Endometrial Stromal Tumors; Granular Cell Tumor; Immature Teratoma; Malignant Mixed Mesodermal Tumor; Neuroendocrine Carcinomas, Corpus; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Wilms Tumor

Glucagon

hormone secreted by the pancreas; functions to increase blood glucose levels

Neuroendocrine Tumors

Glypican-3

heparan sulfate proteoglycan with elevated expression in hepatocellular carcinoma

1G12, GPC3

Borderline Clear Cell Adenofibroma; Clear Cell Carcinoma, Ovary; Dysgerminoma; Endometrioid Adenocarcinoma, Ovary; Germ Cell Tumors, Uterus; Metastatic Melanoma; Microcystic Stromal Tumor; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Yolk Sac Tumor, Ovary; Yolk Sac Tumor, Vagina

Gross cystic fluid protein 15

GCDFP-15, SABP, GPIP4, Gp17, 23A3, BRST-2, D6

Metastatic/Secondary Tumors to the Cervix

H-caldesmon

High molecular weight caldesmon, H-CD

Adenomatoid Tumor, Fallopian Tube; Alveolar Soft Part Sarcoma; Atypical Polypoid Adenomyoma; Benign and Low-Grade Endometrial Stromal Tumors; Dermatofibrosarcoma Protuberans; Disseminated Peritoneal Leiomyomatosis; Endocervical Polyp; Endocervical-Type Adenomyoma; Extragastrointestinal Stromal Tumor; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; High-Grade Endometrial Stromal Sarcoma; Inflammatory Myofibroblastic Tumor; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Malignant Melanoma, Vulva; Ovarian Involvement by Gastrointestinal Stromal Tumor; Peritoneal Inclusion Cysts; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Squamous Cell Carcinoma, Vulva; Undifferentiated Uterine Sarcoma

HBME-1

mesothelioma antibody

Adenomatoid Tumor, Corpus; Malignant Mesothelioma, Peritoneum; Struma Ovarii

HCG

human chorionic gonadotropin

Dysgerminoma; Leiomyosarcoma; Nongestational Choriocarcinoma

HCG-β

human chorionic gonadotropin beta subunit

Endometrioid Adenocarcinoma and Variants, Corpus

Hep-Par1

hepatocyte paraffin 1

OCH1E5.2.10, HEPPAR1

Hepatoid Carcinoma; Yolk Sac Tumor, Ovary

Hepatocyte nuclear factor

HNF-1-α, HNF-1-β

Clear Cell Adenocarcinoma, Corpus; Microglandular Hyperplasia

HER2

v-erb-b2 erythroblastic leukemia viral gene protein, human epidermal growth factor receptor 2

c-erb-B2, HER2/neu, NEU, HER-2, NCL-CBE1, 10A7, 9G6.10, SP3, 4B5, epidermal growth factor receptor 2, P185, 9G6.20, A0485, C-ERBB-2, CB11, ERBB-2, 3B5, TAB250, HERCEPTEST, E2-4001, HER-2_NEU

Extramammary Paget Disease; Mucinous Adenocarcinoma, Ovary; Serous Adenocarcinoma, Corpus

HIK1083

Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinoma, Minimal Deviation; Adenocarcinomas, Non-Clear Cell Type; Deep Glands and Cysts; Endocervical Glandular Hyperplasia (Diffuse and Lobular); Endocervical-Type Adenomyoma; Tunnel Clusters

Histone deacetylase 8

HDAC8, T-19

Uterine Tumors Resembling Ovarian Sex Cord Tumors

HLA-G

human leukocyte antigen G

4H84

Squamous Intraepithelial Lesion/Dysplasia

HMB-45

antigen present in melanocytic tumors such as melanomas

LB39 AA, CMM1, CMM, DNS, FAMMM, MART-1, Melan-A, MLM, tyrosinase

Adenocarcinoma, Clear Cell, Cervix; Alveolar Soft Part Sarcoma; Atypical Nevus of the Genital Tract; Clear Cell Adenocarcinoma, Corpus; Dermatofibrosarcoma Protuberans; Disseminated Peritoneal Leiomyomatosis; Dysgerminoma; Epithelioid Sarcoma; Extramammary Paget Disease; Hepatoid Carcinoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Leiomyoma and Variants; Leiomyosarcoma; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Melanoma; Metastatic Lung Carcinoma; Metastatic Melanoma; Mucosal Melanotic Macule; Perivascular Epithelioid Cell (PEC) Proliferations; Secondary Neoplasms, Uterus; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Steroid Cell Tumor, Not Otherwise Specified; Struma Ovarii; Leiomyoma and Variants; Serous Adenocarcinoma, Corpus; Solitary Fibrous Tumor, Vulva

HMGA2

high mobility group chromatin protein A2

Leiomyoma and Variants; Serous Adenocarcinoma, Corpus; Solitary Fibrous Tumor, Vulva

HNF-1

hepatocyte nuclear factor

Struma Ovarii

HNF-1-α

hepatocyte nuclear factor 1 alpha

Struma Ovarii

HNF-1-β

hepatocyte nuclear factor 1 beta

Adenocarcinoma, Clear Cell, Cervix; Borderline Clear Cell Adenofibroma; Dysgerminoma; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; High-Grade Serous Adenocarcinoma; Juvenile Granulosa Cell Tumor; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Mesonephric Adenocarcinoma; Microglandular Hyperplasia; Secondary Neoplasms, Vagina; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Ovary; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Squamous Cell Carcinoma, Cervix; Stromal Luteoma; Yolk Sac Tumor, Ovary

HPL

human placental lactogen

Clear Cell Adenocarcinoma, Corpus; Nongestational Choriocarcinoma; Squamous Cell Carcinoma, Cervix; Squamous Cell Carcinoma, Corpus

HPV

human papillomavirus

Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Cervical Infections; Lymphomas and Leukemias of the Lower Genital Tract; Malignant Melanoma, Vulva; Malignant Mixed Müllerian Tumor, Cervix; Mesonephric Adenocarcinoma; Mesonephric Remnants/Hyperplasia; Metastatic Cervical Carcinoma; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Ovary; Neuroendocrine Carcinomas, Corpus; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Squamous Cell Carcinoma, Corpus; Transitional Cell Metaplasia; Vulvar Intraepithelial Neoplasia

HPV 18

human papillomavirus 18

Adenosquamous Carcinoma Including Glassy Cell Carcinoma

HSV

herpes simplex virus

Endometritis

HSV1

herpes simplex virus 1

Cervical Infections; Herpes Simplex Virus

HSV2

herpes simplex virus 2

Cervical Infections; Herpes Simplex Virus

Human placental lactogen

HPL

Perivascular Epithelioid Cell (PEC) Proliferations

IL-15

interleukin 15

Fixed Drug Eruption

IMP2

Serous Adenocarcinoma, Corpus

IMP3

IMP3 protein homolog

Serous Adenocarcinoma, Corpus

Inhibin

hormone released from testes or ovaries that down-regulates FSH synthesis and secretion

R1, beta A subunit, INHIBIN

Adult Granulosa Cell Tumor; Benign and Low-Grade Endometrial Stromal Tumors; Benign Brenner Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Clear Cell Adenocarcinoma, Corpus; Deciduosis; Dysgerminoma; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Female Adnexal Tumor of Probable Wolffian Origin; Fibromatous Neoplasms; Follicular Cysts; Gonadoblastoma; Hepatoid Carcinoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Juvenile Granulosa Cell Tumor; Large Cell Neuroendocrine Carcinoma; Large Solitary Luteinized Follicle Cyst of Pregnancy; Leiomyoma and Variants; Leiomyosarcoma; Leydig Cell Tumor; Luteinized Thecoma With Sclerosing Peritonitis; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Malignant Mixed Mesodermal Tumor; Melanoma; Mesodermal Adenosarcoma; Mesonephric Adenocarcinoma; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Metastatic Melanoma; Microcystic Stromal Tumor; Müllerian Adenosarcoma, Cervix; Nongestational Choriocarcinoma; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Perivascular Epithelioid Cell (PEC) Proliferations; Proliferating/Borderline Brenner Tumor; Sclerosing Stromal Tumor; Serous Borderline Tumor, Ovary; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord Tumor With Annular Tubules; Sex Cord-Stromal Tumor, Not Otherwise Specified; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Squamous Cell Carcinoma, Cervix; Squamous Cell Carcinoma, Corpus; Squamous Intraepithelial Lesion/Dysplasia; Steroid Cell Tumor, Not Otherwise Specified; Stromal Hyperplasia and Hyperthecosis; Stromal Luteoma; Struma Ovarii; Strumal Carcinoid; Thecoma; Transitional Cell Carcinoma (Non-Brenner Type); Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Yolk Sac Tumor, Ovary

Inhibin-α

produced by ovarina granulosa cells; inhibits production or secretion of pituitary gonadotropins, a sensitive marker for majority of sex cord-stromal tumors

Benign Müllerian Lesions

INI1

member of SWI/SNF chromatin remodeling complex

BAF47/SNF5, SNF5

Epithelioid Sarcoma; Rhabdomyosarcoma, Corpus; Smooth Muscle Tumors, Vulva

Insulin

peptide hormone produced in islets of Langerhans in pancreas

HB125

Neuroendocrine Tumors

Ki-67

marker of cell proliferation

MMI, KI88, IVAK-2, MIB1

Atypical Nevus of the Genital Tract; Cervical Infections; Clear Cell Adenocarcinoma, Corpus; Endometrial Metaplasias; Endometrial Polyp; Fallopian Tube Metaplasia; Granular Cell Tumor; High-Grade Serous Adenocarcinoma; Immature Squamous Metaplasia, Cervix; Metaplastic Papillary Tumor; Microcystic Adnexal Carcinoma; Ovarian Lymphomas and Leukemias; Pseudocarcinomatous Hyperplasia; Sebaceous Carcinoma; Sebaceous Hyperplasia; Serous Adenocarcinoma, Corpus; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Squamous Intraepithelial Lesion/Dysplasia; Trichoepithelioma; Tunnel Clusters; Vaginal Intraepithelial Neoplasia; Vulvar Intraepithelial Neoplasia; Adenocarcinoma In Situ, Including Variants, Cervix; Tunnel Clusters

LCA

leukocyte common antigen

PD7/26, 1.22/4.14, T29/33, CD45RB, RP2/18, CD45, PD7, 2D1, 2B11+PD7/26

Endometrioid Adenocarcinoma and Variants, Corpus; Small Cell Carcinoma of Ovary, Hypercalcemic Type

LEU-7

β-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)

CD57, NK1, HNK-1, TB01, B3GAT1

Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors

LEU-M1

reacts with Reed-Sternberg cells of Hodgkin disease and with granulocytes

VIM-2, 3C4, CD15, TU9, VIM-D5, MY1, CBD1, MMA, 3CD1, C3D1, Lewis x, SSEA-1

Florid Mesothelial Hyperplasia; Intraabdominal Desmoplastic Small Round Cell Tumor; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Peritoneal Inclusion Cysts; Sebaceous Carcinoma; Serous Borderline Tumor, Ovary; Serous Carcinoma, Peritoneum

Leukocyte common antigen

LCA, PD7/26, 1.22/4.14, T29/33, CD45RB, RP2/18, CD45, PD7, 2D1, 2B11+PD7/26

Intraabdominal Desmoplastic Small Round Cell Tumor

LH

lutenizing hormone

beta-LH

Autoimmune Oophoritis

LIN28

zinc finger CCHC domain containing 1 antibody

Tex17, ZCCHC1, CSDD1, AL024421

Dysgerminoma

Lysozyme

1,4-beta N-acetylmuramidase C

Lyz, Lzm, Ec3.2.1.17

Cervical Infections; Lymphoma and Leukemia, Uterus; Neuroendocrine Tumors; Ovarian Lymphomas and Leukemias

MAGE-A4

melanoma antigen family

Mage-4, 57B

Dysgerminoma

Mammaglobin

breast tissue-specific glycoprotein

304-1A5

Endometrioid Adenocarcinoma, Ovary; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Metastatic/Secondary Tumors to the Cervix; Sclerosing Stromal Tumor; Secondary Neoplasms, Vagina; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum

MART-1

mart-1 clone of Melan A

Atypical Nevus of the Genital Tract; Dermatofibrosarcoma Protuberans; Dysgerminoma; Extramammary Paget Disease; Malignant Melanoma, Vulva; Metastatic Melanoma; Mucosal Melanotic Macule; Smooth Muscle Tumors, Vulva

mCEA

carcinoembryonic antigen, monoclonal

CEA-M, mCEA, CEA-B18, CEA-D14, CEAGOLD 1, T84.6, CEA-GOLD 2, CEA 11, CEA-GOLD 3, CEA 27, CEAGOLD 4, CEA 41, CEA-GOLD 5, T84.1, CEA-M, A5B7, CEJ065, IL-7, T84.66, TF3H8-1, 0062, D14, alpha-7, PARLAM 1, ZC23, CEM010, A115, COL-1, AF4, 12.140.10, 11-7, M773, CEA-M431_31, CEJO65

Endometrioid Adenocarcinoma and Variants, Corpus; Pseudomyxoma Peritonei

Mel-5

Atypical Nevus of the Genital Tract

MEL-CAM

melanoma cell adhesion molecule

CD146, MN4, MUC18

Deciduosis; Leiomyosarcoma; Squamous Cell Carcinoma, Corpus

Melan-A

melanoma antigen recognized by T cells 1 (MART-1); protein found on melanocytes; melanocyte differentiation antigen

M2-7C10, CK-MM

Adenocarcinoma, Clear Cell, Cervix; Alveolar Soft Part Sarcoma; Benign and Low-Grade Endometrial Stromal Tumors; Clear Cell Adenocarcinoma, Corpus; Disseminated Peritoneal Leiomyomatosis; Epithelioid Sarcoma; Extramammary Paget Disease; Hepatoid Carcinoma; Leiomyoma and Variants; Leiomyosarcoma; Leydig Cell Tumor; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Melanoma; Metastatic Lung Carcinoma; Metastatic Melanoma; Mucosal Melanotic Macule; Müllerian Adenosarcoma, Cervix; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Perivascular Epithelioid Cell (PEC) Proliferations; Pregnancy Luteoma; Secondary Neoplasms, Uterus; Sertoli-Leydig Cell Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Smooth Muscle Tumors, Ovary; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Steroid Cell Tumor, Not Otherwise Specified; Stromal Luteoma; Struma Ovarii; Thecoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors

Mesothelin

5B2

Benign Müllerian Lesions; Malignant Mesothelioma, Peritoneum; Metastatic Breast Carcinoma; Metastatic Pancreaticobiliary Adenocarcinoma; Well-Differentiated Papillary Mesothelioma

MIB1

marker of cell proliferation

Ki-67

Adenocarcinoma In Situ, Including Variants, Cervix; Arias-Stella Reaction; Atrophy; Deep Glands and Cysts; Ectopic Prostate; Immature Squamous Metaplasia, Cervix; Leiomyoma and Variants; Microglandular Hyperplasia; Müllerian Papilloma; Serous Carcinoma (Including STIC)

Microphthalmia transcription factor

MITF, 34CA5, D5, C5+D5

Clear Cell Adenocarcinoma, Corpus

MITF

microphthalmia transcription factor

34CA5, D5, C5+D5

Alveolar Soft Part Sarcoma; Epithelioid Sarcoma; Extramammary Paget Disease; Leydig Cell Tumor; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Melanoma; Metastatic Lung Carcinoma; Metastatic Melanoma; Perivascular Epithelioid Cell (PEC) Proliferations; Small Cell Carcinoma of Ovary, Hypercalcemic Type

MLH1

mutL homolog 1

HMLH1, G168-15, G168-728, MMR family; HNPCC2, COCA2

Endometrioid Adenocarcinoma and Variants, Corpus; Sebaceous Carcinoma; Undifferentiated Carcinoma, Corpus

MOC-31

lung cancer marker

Adenomatoid Tumor, Corpus; Florid Mesothelial Hyperplasia; Intraabdominal Desmoplastic Small Round Cell Tumor; Malignant Mesothelioma, Peritoneum; Peritoneal Inclusion Cysts; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Well-Differentiated Papillary Mesothelioma

MSA

muscle-specific actin

ACTIN-SM, ASM-1, CGA7, 1A4, HUC1-1

Intraabdominal Desmoplastic Small Round Cell Tumor

MSH2

mutS homolog 2

FE11

Borderline Clear Cell Adenofibroma; Endometrioid Adenocarcinoma and Variants, Corpus; Sebaceous Carcinoma

MSH6

mut S homolog 6

clone 44, GRBP.P1, DNA mismatch repair protein MSH6 antibody, G/T mismatch binding protein antibody, GTBP antibody, GTMBP antibody, HNPCC 5 antibody, HNPCC5 antibody, HSAP

Borderline Clear Cell Adenofibroma; Endometrioid Adenocarcinoma and Variants, Corpus; Sebaceous Carcinoma

MUC1

epithelial membrane antigen

LICR-LON-M8, BC3, DF3, VU3D1, MUSEII, RD-1, MA695, MA552, PS2P446, 115D8

Extramammary Paget Disease; Fallopian Tube Metaplasia; Malignant Melanoma, Vulva

MUC2

mucin 2, intestinal

CCP58, MUC2-P, M53, MRP, LUM2-3, LDQ10

Extramammary Paget Disease; Malignant Melanoma, Vulva; Pseudomyxoma Peritonei

MUC5

mucin 5AC, tracheobronchial, gastric

CLH2 2, 45M1, MUC5AC, CLH2

Extramammary Paget Disease; Malignant Melanoma, Vulva

MUC5AC

mucin 5AC, tracheobronchial, gastric

MUC5, CLH2 2, 45M1, MUC5AC, CLH2

Extramammary Paget Disease

MUC6

mucin 6, gastric

CLH5

Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinomas, Non-Clear Cell Type; Fallopian Tube Metaplasia

Muscle-specific actin

MSA, ACTIN-SM, ASM-1, CGA7, 1A4, HUC1-1

Rhabdomyoma; Rhabdomyosarcoma, Cervix

Myeloperoxidase

MPO

Cervical Infections; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Neuroendocrine Tumors; Ovarian Lymphomas and Leukemias

MYF4

myogenin

F5D, MYF3, LO26

Intraabdominal Desmoplastic Small Round Cell Tumor

MYOD1

myogenic differentiation 1

5.8A, 5.2F

Alveolar Soft Part Sarcoma; Benign and Low-Grade Endometrial Stromal Tumors; Inflammatory Myofibroblastic Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Leiomyoma and Variants; Leiomyosarcoma; Malignant Mixed Mesodermal Tumor; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Yolk Sac Tumor, Vagina

Myogenin

MYF4, F5D, MYF3, LO26

Benign and Low-Grade Endometrial Stromal Tumors; Inflammatory Myofibroblastic Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Leiomyosarcoma; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Corpus; Müllerian Papilloma; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Yolk Sac Tumor, Vagina

Myoglobin

iron and oxygen-building protein found in muscle tissue

MG-1

Benign and Low-Grade Endometrial Stromal Tumors; Inflammatory Myofibroblastic Tumor; Leiomyosarcoma; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Wilms Tumor; Yolk Sac Tumor, Vagina

Myosin

motor protein responsible for actinbased motility

Leiomyoma and Variants; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Uterine Tumors Resembling Ovarian Sex Cord Tumors

Myosin heavy chain smooth muscle

SMHC, ID8, SM MYOSIN H, HSM-V, SMMS-1

Uterine Tumors Resembling Ovarian Sex Cord Tumors

NANOG

embryonic stem cell-specific homeobox protein

AF 1997

Dysgerminoma; Yolk Sac Tumor, Ovary

Napsin-A

napsin A aspartic peptidase

TMU-AD02

Clear Cell Carcinoma, Ovary; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Malignant Mesothelioma, Peritoneum; Metastatic Lung Carcinoma; Squamous Cell Carcinoma, Cervix; Struma Ovarii

Nestin

neural stem cell marker

10C2

Extragastrointestinal Stromal Tumor

NKI/C3

tetraspan intracellular granule protein

CD63, basophil activation test in allergy

Verruciform Xanthoma

NSE

neuron specific enolase

BSS/H14

Adenoid Basal Carcinoma; Adenoid Cystic Carcinoma; Alveolar Soft Part Sarcoma; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Dysgerminoma; Granular Cell Tumor; Immature Teratoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Large Cell Neuroendocrine Carcinoma; Malignant Mixed Mesodermal Tumor; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Metastatic Gastric Carcinoma; Metastatic Lung Carcinoma; Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Struma Ovarii; Strumal Carcinoid; Wilms Tumor

NY-ESO-1

cancer/testis antigen 1B

CST6, ES121, CTAG-1B

Dysgerminoma

OCT4

octamer-binding transcription factor-3

OCT3, POU5F1 (OCT3/4), C-10

Clear Cell Carcinoma, Ovary; Dysgerminoma; Gonadoblastoma; Immature Teratoma; Sertoli Cell Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Yolk Sac Tumor, Ovary

Oxytocin

OTR, oxytocin RE

Leiomyoma and Variants

P-cadherin

placental dependant adhesion protein

clone 56

Malignant Mixed Müllerian Tumor, Corpus

p16

cyclin dependent kinase 4 inhibitor A

Cyclin dependent kinase inhibitor p16 antibody, INK4, INK4a, MLM, MTS1, multiple tumor suppressor 1 antibody, p12, p14, p16 γ, p16 INK4, p16 INK4a, INK4 p19, TP16, P16_INK4A, E6H4, sc1661, JC8, ZJ11, G175-405, F-12, DCS-50, 6H12, 16P07, 16P04

Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Adenocarcinoma, Villoglandular; Adenoid Basal Carcinoma; Adenosquamous Carcinoma Including Glassy Cell Carcinoma; Atrophy; Bartholin Gland Carcinoma; Basal Cell Carcinoma; Benign Müllerian Lesions; Cellular Angiofibroma; Clear Cell Adenocarcinoma, Corpus; Ectopic Prostate; Endocervical Polyp; Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Endometriosis, Cervix; Extramammary Paget Disease; Fibromatous Neoplasms; High-Grade Serous Adenocarcinoma; Immature Squamous Metaplasia, Cervix; Leiomyoma and Variants; Leiomyosarcoma; Lichen Sclerosus; Low-Grade Serous Adenocarcinoma; Lymphomas and Leukemias of the Lower Genital Tract; Malignant Brenner Tumor; Malignant Melanoma, Vulva; Malignant Mesothelioma, Peritoneum; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Cervix; Malignant Mixed Müllerian Tumor, Corpus; Mesonephric Adenocarcinoma; Mesonephric Remnants/Hyperplasia; Metastatic Cervical Carcinoma; Metastatic Pancreaticobiliary Adenocarcinoma; Metastatic/Secondary Tumors to the Cervix; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Corpus; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Intestinal Type; Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors; Nongestational Choriocarcinoma; Proliferating/Borderline Brenner Tumor; Pseudocarcinomatous Hyperplasia; Sebaceous Carcinoma; Secondary Neoplasms, Uterus; Secondary Tumors in Teratomas; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Squamous Cell Carcinoma, Cervix; Squamous Cell Carcinoma, Corpus; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Squamous Intraepithelial Lesion/Dysplasia; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Transitional Cell Metaplasia; Tubal and Tuboendometrioid Metaplasia; Tunnel Clusters; Vaginal Intraepithelial Neoplasia; Vulvar Intraepithelial Neoplasia

p40

p40 tax antibody

HTLV-1

Metastatic Lung Carcinoma

p53

p53 tumor suppressor gene protein

DO7, 21N, BP53-12-1, AB6, CM1, PAB1801, DO1, BP53-11, PAB240, RSP53, MU195, PAB1801, nuclear p53, P53

Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenoid Basal Carcinoma; Basal Cell Carcinoma; Borderline Clear Cell Adenofibroma; Clear Cell Adenocarcinoma, Corpus; Clear Cell Carcinoma, Ovary; Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Fallopian Tube Metaplasia; Florid Mesothelial Hyperplasia; Granular Cell Tumor; High-Grade Serous Adenocarcinoma; Leiomyoma and Variants; Leiomyosarcoma; Lichen Sclerosus; Low-Grade Serous Adenocarcinoma; Malignant Brenner Tumor; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Corpus; Metaplastic Papillary Tumor; Metastatic Uterine Corpus Carcinoma to Ovary; Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors; Proliferating/Borderline Brenner Tumor; Pseudocarcinomatous Hyperplasia; Salpingitis; Sebaceous Carcinoma; Sebaceous Hyperplasia; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Squamous Intraepithelial Lesion/Dysplasia; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Undifferentiated Uterine Sarcoma; Vulvar Intraepithelial Neoplasia

p63

tumor protein p63

P63-P53 homologous nuclear protein; DELTA-NP63, 4A4, P63, H-137, 7JUL

Adenocarcinoma In Situ, Including Variants, Cervix; Adenoid Basal Carcinoma; Adenosquamous Carcinoma Including Glassy Cell Carcinoma; Benign Brenner Tumor; Benign Müllerian Lesions; Eccrine Spiradenoma; Ectopic Prostate; Endometrioid Adenocarcinoma and Variants, Corpus; Epithelioid Sarcoma; Fallopian Tube Metaplasia; Hidradenoma Papilliferum; Immature Squamous Metaplasia, Cervix; Leiomyosarcoma; Malignant Melanoma, Vulva; Metastatic Cervical Carcinoma; Metastatic Lung Carcinoma; Microcystic Adnexal Carcinoma; Microglandular Hyperplasia; Mixed Tumor, Vulva; Mucinous Borderline Tumor, Endocervical Type; Neuroendocrine Tumors; Nongestational Choriocarcinoma; Proliferating/Borderline Brenner Tumor; Sebaceous Carcinoma; Secondary Neoplasms, Vagina; Squamous Cell Carcinoma, Cervix; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Squamous Intraepithelial Lesion/Dysplasia; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Transitional Cell Metaplasia; Vulvar Intraepithelial Neoplasia

p504S

alpha-methylacyl-CoA racemase (AMACR)

13H4, AMACR

Metastatic Colorectal Carcinoma

p75

Malignant Melanoma, Vulva

Pan keratin

cytokeratin-pan (AE1/AE3/LP34); cocktail of high and low molecular weight cytokeratins

keratin pan, MAK-6, K576, LU-5, KL-1, KC-8, MNF 116, pankeratin, pancytokeratin

Benign Müllerian Lesions; Hepatoid Carcinoma

Pancytokeratin

cytokeratin-pan (AE1/AE3/LP34); cocktail of high and low molecular weight cytokeratins

keratin pan, MAK-6, K576, LU-5, KL-1, KC-8, MNF 116, pankeratin, pan keratin

Malignant Mesothelioma, Peritoneum

PAP

prostatic acid phosphatase

PASE/4LJ, PAP-P

Polyps

pax-2

paired box gene 2

Z-RX2, PAX-2

Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Endometrioid, Cervix; Deep Glands and Cysts; Endocervicosis; Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia; Endometriosis, Cervix; Low-Grade Serous Adenocarcinoma; Malignant Mesothelioma, Peritoneum; Mesonephric Remnants/Hyperplasia; Müllerian Papilloma; Serous Carcinoma, Peritoneum; Tubal and Tuboendometrioid Metaplasia; Tunnel Clusters

pax-8

paired box gene 8

Adenomatoid Tumor, Corpus; Alveolar Soft Part Sarcoma; Benign Müllerian Lesions; Benign Serous Tumors, Ovary; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Clear Cell Carcinoma, Ovary; Deep Glands and Cysts; Dysgerminoma; Endocervicosis; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid Borderline Tumor; Female Adnexal Tumor of Probable Wolffian Origin; Florid Mesothelial Hyperplasia; Germ Cell Tumors, Uterus; High-Grade Serous Adenocarcinoma; Low-Grade Serous Adenocarcinoma; Malignant Brenner Tumor; Malignant Mesothelioma, Peritoneum; Mesonephric Adenocarcinoma; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Lung Carcinoma; Metastatic Melanoma; Metastatic/Secondary Tumors to the Cervix; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Intestinal Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Peritoneal Inclusion Cysts; Proliferating/Borderline Brenner Tumor; Secondary Neoplasms, Uterus; Secondary Neoplasms, Vagina; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Sertoli Cell Tumor; Stromal Luteoma; Struma Ovarii; Strumal Carcinoid; Well-Differentiated Papillary Mesothelioma; Yolk Sac Tumor, Ovary

pCEA

carcinoembryonic antigen, polyclonal

Hepatoid Carcinoma; Pseudomyxoma Peritonei

Perilipin

Extramammary Paget Disease

PHLDA1

Trichoepithelioma

PKC-θ

protein kinase C theta

Clone 27, PKC-Theta

Ovarian Involvement by Gastrointestinal Stromal Tumor

PLAP

placental alkaline phosphatase

228M, 8A9, 88B

Dysgerminoma; Sertoli Cell Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Squamous Intraepithelial Lesion/Dysplasia; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor

PMS2

Endometrioid Adenocarcinoma and Variants, Corpus; Undifferentiated Carcinoma, Corpus

Podoplanin

transmembrane mucoprotein (38 kd) recognized by the D2-40 monoclonal antibody

D2-40, M2A

Eccrine Spiradenoma; Florid Mesothelial Hyperplasia; Gonadoblastoma; Malignant Mesothelioma, Peritoneum; Microcystic Adnexal Carcinoma; Peritoneal Inclusion Cysts

POU5F1

octamer-binding transcription factor-

OCT3, OCT4, C-10

Gonadoblastoma

PR

progesterone receptor protein

PRP, 10A9, PGR-1A6, KD68, PGR-ICA, PRP-P, PRI, 1A6, 1AR, HPRA3, PGR-636, 636, PR88, NCL-PGR

Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Angiomyofibroblastoma; Atypical Polypoid Adenomyoma; Benign and Low-Grade Endometrial Stromal Tumors; Benign Müllerian Lesions; Borderline Clear Cell Adenofibroma; Clear Cell Adenocarcinoma, Corpus; Clear Cell Carcinoma, Ovary; Deep Aggressive Angiomyxoma; Disseminated Peritoneal Leiomyomatosis; Endocervicosis; Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid Borderline Tumor; Endometriosis and Deciduosis; Endometriosis, Cervix; Extragastrointestinal Stromal Tumor; Extramammary Paget Disease; Fibroadenoma and Phyllodes Tumor; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; Hepatoid Carcinoma; Hidradenoma Papilliferum; High-Grade Endometrial Stromal Sarcoma; High-Grade Serous Adenocarcinoma; Inflammatory Myofibroblastic Tumor; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Low-Grade Serous Adenocarcinoma; Luteinized Thecoma With Sclerosing Peritonitis; Lymphoma and Leukemia, Uterus; Malignant Mesothelioma, Peritoneum; Malignant Mixed Müllerian Tumor, Corpus; Mesodermal Adenosarcoma; Mesonephric Adenocarcinoma; Metastatic Breast Carcinoma; Metastatic/Secondary Tumors to the Cervix; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Corpus; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Endocervical Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Müllerian Adenosarcoma, Cervix; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Rhabdomyoma; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Secondary Neoplasms, Uterus; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Sex Cord-Stromal Tumor, Not Otherwise Specified; Small Cell Carcinoma, Pulmonary Type; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Squamous Cell Carcinoma, Corpus; Stromal Luteoma; Syringoma; Thecoma; Tubal and Tuboendometrioid Metaplasia; Undifferentiated Carcinoma, Corpus; Undifferentiated Uterine Sarcoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Wilms Tumor; Yolk Sac Tumor, Vagina

ProEx C

cocktail of monoclonal antibodies against proteins associated with aberrant S-phase cell cycle induction (topoisomerase IIA, minichromosome maintenance protein 2)

Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Usual Type; Atrophy; Microglandular Hyperplasia; Tubal and Tuboendometrioid Metaplasia; Endometrioid Adenocarcinoma and Variants, Corpus

Progesterone receptor

PR, PRP, 10A9, PGR-1A6, KD68, PGRICA, PRP-P, PRI, 1A6, 1AR, HPRA3, PGR-636, 636, PR88, NCL-PGR

Fibroepithelial Stromal Polyp; Mixed Tumor, Vagina; Polyps

Prostate stem cell antigen

PSCA, 1G8

Metastatic Pancreaticobiliary Adenocarcinoma

PSA

prostate specific antigen

ER-PR8, PSA-P, F5

Ectopic Prostate; Polyps

PSAP

prostatic acid phosphatase

PAP, PASE/4LJ, PAP-P

Ectopic Prostate;

PTAH

Rhabdomyoma; Rhabdomyosarcoma, Corpus

PTEN

phosphatase and tensin homolog

PN37

Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia

RCC

renal cell carcinoma

66.4C2, PN-15, RCC, RCC MA

Alveolar Soft Part Sarcoma; Müllerian Papilloma; Secondary Neoplasms, Vagina; Struma Ovarii

S100

low molecular weight protein normally present in cells derived from neural crest (Schwann cells, melanocytes, and glial cells), chondrocytes, adipocytes, myoepithelial cells, macrophages, Langerhans cells, dendritic cells, and keratinocytes

S-100, A6, 15E2E2, Z311, 4C4.9, S100 protein

Adenocarcinoma, Clear Cell, Cervix; Adenoid Cystic Carcinoma; Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Angiomyofibroblastoma; Atypical Nevus of the Genital Tract; Cellular Angiofibroma; Deep Aggressive Angiomyxoma; Dermatofibrosarcoma Protuberans; Dysgerminoma; Epithelioid Sarcoma; Extragastrointestinal Stromal Tumor; Extramammary Paget Disease; Granular Cell Tumor; Hepatoid Carcinoma; Hidradenoma Papilliferum; Immature Teratoma; Inflammatory Myofibroblastic Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Juvenile Granulosa Cell Tumor; Leiomyosarcoma; Lymphomas and Leukemias of the Lower Genital Tract; Malakoplakia; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Melanoma; Metastatic Lung Carcinoma; Metastatic Melanoma; Mixed Tumor, Vagina; Mixed Tumor, Vulva; Ovarian Involvement by Gastrointestinal Stromal Tumor; Perivascular Epithelioid Cell (PEC) Proliferations; Prepubertal Vulval Fibroma; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Secondary Neoplasms, Uterus; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Solitary Fibrous Tumor, Vulva; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Steroid Cell Tumor, Not Otherwise Specified; Struma Ovarii; Superficial Angiomyxoma; Undifferentiated Carcinoma, Corpus; Verruciform Xanthoma

SALL4

sal-like protein 4

Borderline Clear Cell Adenofibroma; Clear Cell Carcinoma, Ovary; Dysgerminoma; Endometrioid Adenocarcinoma, Ovary; Germ Cell Tumors, Uterus; Gonadoblastoma; Hepatoid Carcinoma; Immature Teratoma; Juvenile Granulosa Cell Tumor; Metastatic Melanoma; Microcystic Stromal Tumor; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Yolk Sac Tumor, Ovary; Yolk Sac Tumor, Vagina

Serotonin

5-hydroxytryptamine (5-HT), a monoamine neurotransmitter

5-HT, 5HT-H209

Benign Brenner Tumor; Neuroendocrine Tumors; Strumal Carcinoid; Transitional Cell Metaplasia

SF1

steroidogenic factor-1

AD4BP

Adult Granulosa Cell Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Endometrioid Adenocarcinoma, Ovary; Female Adnexal Tumor of Probable Wolffian Origin; Fibromatous Neoplasms; Gonadoblastoma; Hepatoid Carcinoma; Juvenile Granulosa Cell Tumor; Large Cell Neuroendocrine Carcinoma; Leydig Cell Tumor; Luteinized Thecoma With Sclerosing Peritonitis; Metastatic Appendiceal Tumors; Metastatic Melanoma; Serous Borderline Tumor, Ovary; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Steroid Cell Tumor, Not Otherwise Specified; Struma Ovarii; Strumal Carcinoid; Transitional Cell Carcinoma (Non-Brenner Type); Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Yolk Sac Tumor, Ovary

SMA

actin, smooth muscle

Actin-sm, ASM-1, CGA7, 1A4, HUC1-1

Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Extragastrointestinal Stromal Tumor; Fibromatous Neoplasms; Luteinized Thecoma With Sclerosing Peritonitis; Thecoma

SMA-α

actin, smooth muscle, alpha

Hidradenoma Papilliferum

SMAD4

Similar to mothers against decapentaplegic (MAD); mothers against DPP homolog 4

MADR1 JV4-1, DPC4_SMAD4, B-8

Metastatic Pancreaticobiliary Adenocarcinoma; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Intestinal Type; Secondary Neoplasms, Uterus

SMARCB1

Epithelioid Sarcoma

Smooth muscle actin

SMA, Actin-sm, ASM-1, CGA7, 1A4, HUC1-1

Angiomyofibroblastoma; Disseminated Peritoneal Leiomyomatosis; Endocervical-Type Adenomyoma; Fibroepithelial Stromal Polyp; Inflammatory Myofibroblastic Tumor; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Massive Vulval Edema; Mesodermal Adenosarcoma; Mixed Tumor, Vagina; Müllerian Adenosarcoma, Cervix; Perivascular Epithelioid Cell (PEC) Proliferations; Prepubertal Vulval Fibroma; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Superficial Angiomyxoma

Smoothelin

cytoskeletal protein specific for smooth muscle cells

Extragastrointestinal Stromal Tumor

Somatostatin

Neuroendocrine Tumors

SOX2

SRY (sex-determining region Y)-box 2 protein

SOX2 (AB5603)

Dysgerminoma; Yolk Sac Tumor, Ovary

SOX10

SRY (sex-determining region Y)-box 10 protein

Epithelioid Sarcoma; Malignant Melanoma, Vulva; Melanoma

Survivin

inhibitor of apoptosis

AB469, SURVIVIN, FL-142, D8, 8E12

Sebaceous Hyperplasia

Synaptophysin

major synaptic vesicle protein p38 antibody

SVP38, SY38, SNP-88, SYP, SYPH, Sypl, Syn p38

Adenoid Basal Carcinoma; Adenoid Cystic Carcinoma; Adult Granulosa Cell Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Endometrioid Adenocarcinoma, Ovary; Hepatoid Carcinoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Juvenile Granulosa Cell Tumor; Large Cell Neuroendocrine Carcinoma; Malignant Mixed Mesodermal Tumor; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Metastatic Gastric Carcinoma; Metastatic Lung Carcinoma; Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyosarcoma, Corpus; Sertoli-Leydig Cell Tumor; Sex Cord Tumor With Annular Tubules; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Squamous Cell Carcinoma, Cervix; Struma Ovarii; Strumal Carcinoid; Undifferentiated Carcinoma, Corpus

Syndecan

useful marker for plasma cells

CD138, B-B4, AM411-10M, MI15

Endometritis

TAG72

tumor-associated glycoprotein-72

CC49, B72.3, BRST-3

Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum

TdT

terminal deoxynucleotidyl transferase

SEN 28

Lymphomas and Leukemias of the Lower Genital Tract

TFE3

transcription factor E3

Alveolar Soft Part Sarcoma; Clear Cell Adenocarcinoma, Corpus; Perivascular Epithelioid Cell (PEC) Proliferations; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus

Thrombomodulin

1009,15C8

Adenomatoid Tumor, Corpus; Benign Brenner Tumor; Florid Mesothelial Hyperplasia; Malignant Mesothelioma, Peritoneum; Proliferating/Borderline Brenner Tumor; Serous Carcinoma, Peritoneum; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube

Thyroglobulin

dimetric protein specific to thyroid gland

DAK-TG6

Benign Serous Tumors, Ovary; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Microcystic Stromal Tumor; Struma Ovarii; Strumal Carcinoid

TLE1

transducer like enhancer 1

Dermatofibrosarcoma Protuberans; Extragastrointestinal Stromal Tumor; Pseudomyxoma Peritonei; Solitary Fibrous Tumor, Peritoneum

TNF-α

cytokine involved in systemic inflammation, stimulates the acute phase reaction

Gamma catenin, γ-catenin, G-catenin, alpha alpha, TNF, cachexin, cachectin

Fixed Drug Eruption

TSPY

testis-specific protein, Y-encoded

Dysgerminoma

TTF-1

transcription termination factor

8G7G3/1, SPT-24, SC-13040

Borderline Clear Cell Adenofibroma; Leiomyoma and Variants; Malignant Mesothelioma, Peritoneum; Metastatic Lung Carcinoma; Microcystic Stromal Tumor; Neuroendocrine Tumors; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Struma Ovarii; Strumal Carcinoid

Tyrosinase

catalyzes production of melanin

NCL-TYROS, T311

Extramammary Paget Disease; Malignant Melanoma, Vulva; Melanoma; Metastatic Melanoma

UP3

uroplakin-3

UP III, AU 1

Benign Brenner Tumor

Uroplakin-3

UP3, UP III, AU 1

Benign Brenner Tumor; Extramammary Paget Disease; Malignant Melanoma, Vulva; Proliferating/Borderline Brenner Tumor; Secondary Neoplasms, Vagina; Serous Carcinoma, Peritoneum; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube

Villin

1D2C3

Endometrioid Adenocarcinoma and Variants, Corpus

Vimentin

major subunit protein of intermediate filaments of mesenchymal cells

43BE8, 3B4, V10, V9, VIM-B34, VIM

Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Usual Type; Alveolar Soft Part Sarcoma; Benign and Low-Grade Endometrial Stromal Tumors; Benign Müllerian Lesions; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Fibroadenoma and Phyllodes Tumor; Fibroepithelial Stromal Polyp; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; High-Grade Serous Adenocarcinoma; Leydig Cell Tumor; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Cervix; Malignant Mixed Müllerian Tumor, Corpus; Mesonephric Adenocarcinoma; Metastatic Lung Carcinoma; Metastatic/Secondary Tumors to the Cervix; Microcystic Stromal Tumor; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Corpus; Mucinous Adenocarcinoma, Ovary; Mucinous Cystic Tumor with Mural Nodules; Müllerian Papilloma; Peritoneal Inclusion Cysts; Polyps; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Sclerosing Stromal Tumor; Secondary Neoplasms, Uterus; Sertoli Cell Tumor; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Solitary Fibrous Tumor, Peritoneum; Superficial Angiomyxoma; Tubal and Tuboendometrioid Metaplasia

WT1

Wilms tumor gene-01

6F-H2, C-19, WT1

Adenocarcinoma, Serous, Cervix; Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Benign and Low-Grade Endometrial Stromal Tumors; Benign Brenner Tumor; Benign Müllerian Lesions; Benign Serous Tumors, Ovary; Borderline Clear Cell Adenofibroma; Clear Cell Adenocarcinoma, Corpus; Clear Cell Carcinoma, Ovary; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid Borderline Tumor; Extragastrointestinal Stromal Tumor; Female Adnexal Tumor of Probable Wolffian Origin; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; Hepatoid Carcinoma; High-Grade Serous Adenocarcinoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Intravenous Leiomyomatosis; Juvenile Granulosa Cell Tumor; Leiomyosarcoma; Leydig Cell Tumor; Low-Grade Serous Adenocarcinoma; Lymphoma and Leukemia, Uterus; Malignant Brenner Tumor; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Mesodermal Adenosarcoma; Metastatic Breast Carcinoma; Metastatic Lung Carcinoma; Metastatic Uterine Corpus Carcinoma to Ovary; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Endocervical Type; Mucinous Borderline Tumor, Intestinal Type; Müllerian Adenosarcoma, Cervix; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Proliferating/Borderline Brenner Tumor; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord Tumor With Annular Tubules; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Struma Ovarii; Thecoma; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Well-Differentiated Papillary Mesothelioma; Wilms Tumor